Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a maintenance fee in 2019.

Key Finding 1: Stick With 1 Set of Weight Loss Tactics Whatever tactic people chose to lose weight, survey respondents who did so successfully were more than twice as likely to have remained ...